SHORT PEPTIDES DERIVED FROM VDAC1, COMPOSITIONS AND METHODS OF USE THEREOF

Research output: Patent

Abstract

The present invention relates to short peptides based on the amino acids sequence of the N-terminal domain of the human mitochondrial protein voltage-dependent anion channel 1 (VDAC) and to peptide conjugates further comprising a cell permeability enhancing moiety. The peptides, peptide conjugates and pharmaceutical composition comprising same are useful for treating diseases characterized by cell hyperproliferation or resistance to cell death, particularly cancer.

Original languageEnglish
Patent numberWO2015011711
IPCC07K 19/ 00 A I
Priority date25/07/13
StatePublished - 29 Jan 2015

Fingerprint

Dive into the research topics of 'SHORT PEPTIDES DERIVED FROM VDAC1, COMPOSITIONS AND METHODS OF USE THEREOF'. Together they form a unique fingerprint.

Cite this